Biomarker: I206-IgE American Cockroach

Overview

I206-IgE measures serum immunoglobulin E (IgE) antibodies specific to American cockroach (Periplaneta americana) extract. IgE is an antibody involved in immediate-type allergic responses, and sensitization to cockroach allergens is associated with allergic rhinitis and asthma in some individuals. A detectable result indicates sensitization but does not, by itself, establish that cockroach exposure causes symptoms or determine disease severity. The test is clinically useful as part of an allergy evaluation, particularly when symptoms, exposure history, and other findings suggest cockroach-associated respiratory allergy.

Clinical Use Cases

Assessing sensitization to American cockroach allergens in people with suspected allergic rhinitis, asthma, or other respiratory allergy.
Supporting evaluation of cockroach-associated asthma, especially in patients with relevant indoor exposure.
Identifying possible allergens that may contribute to symptoms and informing environmental exposure-reduction strategies.
Comparing sensitization to American cockroach with sensitization to other cockroach species, house dust mites, or other aeroallergens.
Supporting research on cockroach sensitization, asthma morbidity, allergen exposure, and allergen-specific immune responses.

Specimen Types

Serum from venous blood.
Plasma may be used in some research or laboratory assay formats.

Measurement Methods

In-vitro allergen-specific IgE immunoassay using an American cockroach extract, commonly reported in ( \mathrm{kU_A/L} ) or equivalent units.
Fluorescent enzyme immunoassay, including ImmunoCAP-based testing.
Enzyme-linked immunosorbent assay or immunoblot-based methods in research and some clinical settings.
Skin-prick testing is a complementary in-vivo method for assessing cockroach sensitization, but it does not measure I206-IgE in blood.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergen-specific IgE blood test.
Tell the healthcare professional about all medicines and supplements. Antihistamines can interfere with skin-prick testing, although they generally do not alter the blood measurement itself.
Do not stop prescribed medicines unless instructed by a healthcare professional.
Results should be interpreted with the patient’s symptoms, exposure history, physical examination, and, when appropriate, skin-prick testing. A positive result indicates sensitization and does not necessarily demonstrate clinically relevant allergy.
Cross-reactivity with other cockroach species and allergens, including some shared invertebrate proteins such as tropomyosin, may affect interpretation.
Allergen extracts can vary in composition and potency, and no single test is a definitive gold standard for cockroach hypersensitivity.
Total IgE concentration, age, atopic status, and concurrent sensitization to other indoor allergens may influence the clinical context but do not independently establish American cockroach allergy.